| Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112 (NCT00088517) | National Institute of Mental Health (NIMH) | 2004-07-01 |
| G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers (NCT00082329) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-06-18 |
| 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting (NCT00834587) | Teva Pharmaceuticals USA | 2004-06-01 |
| Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets (NCT01179646) | Kremers Urban Development Company | 2004-06-01 |
| A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions (NCT00863941) | Actavis Inc. | 2004-06-01 |
| Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin (NCT02170844) | Boehringer Ingelheim | 2004-06-01 |
| Evaluation of TEACH (Training Early Achievers for Careers in Health) Research (NCT00204035) | University of Chicago | 2004-06-01 |
| Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma (NCT00404976) | Maastricht University Medical Center | 2004-06-01 |
| Evaluation of Different Interfaces for Noninvasive Positive Pressure Ventilation (NPPV) (NCT00297986) | Policlinico Hospital | 2004-06-01 |
| Effect of Dietary Salt Supplemantation in Vasovagal Syncope Prophylaxis: A Clinical Trial (NCT00465946) | Hospital de Clinicas de Porto Alegre | 2004-06-01 |
| Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions (NCT00829712) | Teva Pharmaceuticals USA | 2004-06-01 |
| Risk Factors of Breastfeeding Study (NCT00195962) | Children's Mercy Hospital Kansas City | 2004-06-01 |
| Effect of Rosiglitazone (NCT00285142) | University Hospital, Montpellier | 2004-06-01 |
| Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions (NCT00829673) | Teva Pharmaceuticals USA | 2004-06-01 |
| Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions (NCT00779805) | Ranbaxy Laboratories Limited | 2004-06-01 |
| Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers (NCT02260050) | Boehringer Ingelheim | 2004-06-01 |
| Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects (NCT01796938) | UCB BIOSCIENCES GmbH | 2004-06-01 |
| To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions (NCT00881400) | Sandoz | 2004-06-01 |
| Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions (NCT00779831) | Ranbaxy Laboratories Limited | 2004-06-01 |
| Dose Response to Recombinant Factor VIIa When Administered for Bleed (NCT00104455) | Novo Nordisk A/S | 2004-06-01 |
| Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers (NCT02261090) | Boehringer Ingelheim | 2004-06-01 |
| 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting (NCT00835497) | Teva Pharmaceuticals USA | 2004-06-01 |
| Epidemiology Controls Using Healthy Participants (NCT00476632) | M.D. Anderson Cancer Center | 2004-06-01 |
| Comparison of Two Liraglutide Formulations in Healthy Volunteers (NCT01508897) | Novo Nordisk A/S | 2004-05-28 |
| Within-subject Variability of Insulin Detemir in Healthy Volunteers (NCT01497535) | Novo Nordisk A/S | 2004-05-27 |
| Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers (NCT00083330) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-18 |
| Role of the Brain in Making Economic Decisions (NCT00083317) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-05-15 |
| Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg (NCT00649519) | Mylan Pharmaceuticals Inc | 2004-05-01 |
| Effects of Naproxen on Physical Performance (NCT00410995) | University of Oklahoma | 2004-05-01 |
| Lansoprazole 30 mg DR Capsule Fasting Study (NCT01045967) | Teva Pharmaceuticals USA | 2004-05-01 |
| Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions (NCT00684814) | Mutual Pharmaceutical Company, Inc. | 2004-05-01 |
| Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects (NCT02262793) | Boehringer Ingelheim | 2004-05-01 |
| A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers. (NCT02246842) | Bio Products Laboratory | 2004-05-01 |
| Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets (NCT00658541) | Mutual Pharmaceutical Company, Inc. | 2004-05-01 |
| Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting (NCT00835354) | Teva Pharmaceuticals USA | 2004-05-01 |
| A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions (NCT00726895) | Mutual Pharmaceutical Company, Inc. | 2004-05-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers (NCT02254122) | Boehringer Ingelheim | 2004-05-01 |
| Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults (NCT00782548) | Actavis Inc. | 2004-05-01 |
| To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions. (NCT00881153) | Sandoz | 2004-05-01 |
| Admixture Mapping of Ethnic and Racial Insulin Complex Outcomes (NCT00726778) | University of Alabama at Birmingham | 2004-05-01 |
| Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg (NCT00648531) | Mylan Pharmaceuticals Inc | 2004-05-01 |
| Comparative Bioavailability Study of Clarithromycin 250 mg Tablets (NCT00648830) | Mylan Pharmaceuticals Inc | 2004-05-01 |
| Use of [18F]FECNT in Positron Emission Tomography (NCT00083629) | National Institute of Mental Health (NIMH) | 2004-05-01 |
| Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions (NCT00778791) | Ranbaxy Laboratories Limited | 2004-04-01 |
| Performance Evaluation and Research for Older Adults Requiring Major Surgery (NCT00487890) | University of Washington | 2004-04-01 |
| Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol (NCT00940329) | AstraZeneca | 2004-04-01 |
| Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg (NCT00648622) | Mylan Pharmaceuticals Inc | 2004-04-01 |
| Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects (NCT02262650) | Boehringer Ingelheim | 2004-04-01 |
| Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions (NCT00778141) | Ranbaxy Laboratories Limited | 2004-04-01 |
| Safety, Tolerability and Pharmacokinetics of Oral BIBP 5371 CL in Healthy Male and Female Volunteers (NCT02256709) | Boehringer Ingelheim | 2004-04-01 |
| A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions (NCT00865436) | Actavis Inc. | 2004-04-01 |
| Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers (NCT01507337) | Novo Nordisk A/S | 2004-04-01 |
| Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions (NCT00834977) | Teva Pharmaceuticals USA | 2004-04-01 |
| Pharmacokinetics of 3 Formulations of Ibuprofen Suppositories (NCT00921830) | Johnson & Johnson Consumer and Personal Products Worldwide | 2004-04-01 |
| Cefprozil for Oral Suspension 250 mg/5 mL, Fasting (NCT00835614) | Teva Pharmaceuticals USA | 2004-04-01 |
| Dutasteride to Treat Women With Menstrually Related Mood Disorders (NCT00082043) | National Institute of Mental Health (NIMH) | 2004-03-31 |
| Rhythm Perception and Generation (NCT00080067) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-03-22 |
| Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg (NCT00648388) | Mylan Pharmaceuticals Inc | 2004-03-01 |
| Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women (NCT02816125) | University of Guelph | 2004-03-01 |
| Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male Volunteers (NCT02264028) | Boehringer Ingelheim | 2004-03-01 |
| Comparison Study of a New Fiberoptic Intubation Device to Standard Intubation Techniques (NCT00906932) | University of Texas Southwestern Medical Center | 2004-03-01 |
| Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial (NCT00692952) | Shanghai Institute of Planned Parenthood Research | 2004-03-01 |
| Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg (NCT00650416) | Mylan Pharmaceuticals Inc | 2004-03-01 |
| Phosphate Intake's Effect on the Skeletal System - Pilot (NCT00187629) | University of California, San Francisco | 2004-03-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers (NCT02259894) | Boehringer Ingelheim | 2004-03-01 |
| To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions (NCT00881855) | Sandoz | 2004-03-01 |
| Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions (NCT01149473) | Teva Pharmaceuticals USA | 2004-03-01 |
| Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers (NCT00135824) | Novartis | 2004-03-01 |
| To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions (NCT00881426) | Sandoz | 2004-03-01 |
| Neuromodulation and Language Acquisition (Project Stage Ia) (NCT00102284) | University Hospital Muenster | 2004-03-01 |
| Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions (NCT00835367) | Teva Pharmaceuticals USA | 2004-03-01 |
| Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones (NCT00447512) | Max-Planck-Institute of Psychiatry | 2004-03-01 |
| Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions (NCT01155895) | Dr. Reddy's Laboratories Limited | 2004-03-01 |
| Brain Activity in Visual-Motor Behavior (NCT00077038) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-02-06 |
| Study of Brain Function During Cognitive Tasks (NCT00076739) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-02-02 |
| Zaleplon 10 mg Capsules Under Non-Fasting Conditions (NCT00829868) | Teva Pharmaceuticals USA | 2004-02-01 |
| Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions (NCT01146041) | Dr. Reddy's Laboratories Limited | 2004-02-01 |
| Increasing Infant Preventive Health Service Delivery in an Inner City Population (NCT00221507) | University of Colorado, Denver | 2004-02-01 |
| Genotype and Phenotype Registry: Enrollment of Normal Control Subjects for Current and Future Research (NCT00926042) | Northwell Health | 2004-02-01 |
| Zaleplon 10mg Capsules Under Fasting Conditions (NCT00829998) | Teva Pharmaceuticals USA | 2004-02-01 |
| Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers (NCT02259933) | Boehringer Ingelheim | 2004-02-01 |
| Prostanoid Levels After Medication to Prevent Pain Following Third Molar (Wisdom Tooth) Extraction (NCT00078104) | National Institute of Dental and Craniofacial Research (NIDCR) | 2004-02-01 |
| Meloxicam 15 mg Tablets Under Fasting Conditions (NCT00840476) | Teva Pharmaceuticals USA | 2004-02-01 |
| Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg (NCT00647647) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| Meloxicam 15 mg Tablets Under Non-Fasting Conditions (NCT00840879) | Teva Pharmaceuticals USA | 2004-02-01 |
| Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers (NCT02253914) | Boehringer Ingelheim | 2004-02-01 |
| Effectiveness of an Internet-Based Curriculum in Increasing Health Care Providers' Knowledge of Herbs and Dietary Supplements (NCT00110539) | National Library of Medicine (NLM) | 2004-02-01 |
| Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions (NCT00805155) | Padagis LLC | 2004-02-01 |
| Pain Pathways in the Brain (NCT00078364) | National Institute of Dental and Craniofacial Research (NIDCR) | 2004-02-01 |
| Cilostazol 50 mg Tablets Under Fasting Conditions (NCT00839930) | Teva Pharmaceuticals USA | 2004-02-01 |
| Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg (NCT00650195) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg (NCT00650234) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg (NCT00649948) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions (NCT00727272) | Mutual Pharmaceutical Company, Inc. | 2004-02-01 |
| Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg (NCT00648713) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| Brain Changes Associated With Learning a Motor Task (NCT00076466) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-01-22 |
| Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams (NCT00803166) | Padagis LLC | 2004-01-01 |
| Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects (NCT00310596) | Bayer | 2004-01-01 |
| Cerebral Responses to Insulin Induced Hypoglycemia (NCT02747680) | University of Minnesota | 2004-01-01 |
| Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers (NCT02273531) | Boehringer Ingelheim | 2004-01-01 |